Retinal pigment epithelial detachments and tears, and progressive retinal degeneration in light chain deposition disease

British Journal of Ophthalmology

Volumn 97, Issue 5, 2013, Pages 627-631

  Spielberg, Leigh H ^a   Heckenlively, John R ^b   Leys, Anita M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; INDOCYANINE GREEN; LENALIDOMIDE;

ADULT; ARTICLE; AUTOFLUORESCENCE; CASE REPORT; DARK ADAPTATION; DRUG WITHDRAWAL; ECHOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEMODIALYSIS; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIGHT CHAIN DEPOSITION DISEASE; MALE; MEDICAL HISTORY; METAMORPHOSIS; NIGHT BLINDNESS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REOPERATION; RETINA DEGENERATION; RETINA DETACHMENT; RETINA TEAR; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL IMPAIRMENT;

COLORING AGENTS; DISEASE PROGRESSION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PARAPROTEINEMIAS; RETINAL DEGENERATION; RETINAL DETACHMENT; RETINAL PERFORATIONS; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84876287339     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302851     Document Type: Article

References (17)

1. Ronco PM, Alyanakian MA, Mougenot B, et al. Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Neph rol 2001;12:1558-65
2. Pozzi C, D'Amico M, Fogazzi GB, et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003;42:1154-63
3. Buxbaum JN, Chuba JV, Hellman GC, et al. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 1990;112:455-64
4. Rho L, Qiu L, Strauchen JA, et al. Pulmonary manifestations of light chain deposition disease. Respirology 2009;14:767-70
5. Popoviæ M, Tavæar R, Glavac D, et al. Light chain deposition disease restricted to the brain: the first case report. Hum Pathol 2007;38:179-84
6. Heilman RL, Velosa JA, Holley KE, et al. Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis 1992;20:34-41
7. Casiraghi M.A. ,De Paoli A ,Assi A ,et al. Hepatic amyloidosis with light chain deposition disease. A rare association. Dig Liver Dis. 2000. 32. 795-8
8. Kyle RA. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997;336:1202-7
9. Enzenauer RJ, Stock JG, Enzenauer RW, et al. Retinal vasculopathy associated with systemic light chain deposition disease. Retina 1990;10:115-18
10. Khan P, Roth MS, Keren DF, et al. Light chain disease associated with the hyperviscosity syndrome. Cancer 1987;60:2267-8
11. Leys A, Spielberg L, Heckenlively JR. Retinal pigment epithelial detachments and tears in light chain deposition disease. Association for Research in Vision and Ophthalmology (ARVO) E-Abstract 2010
12. Daicker BC, Mihatsch MJ, Strøm EH, et al. Ocular pathology in light chain deposition disease. Eur J Ophthalmol 1995;5:75-81
13. Margolis R, Spaide RF. A pilotstudy of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-15
14. Auran JD, Donn A, Hyman GA. Multiple myeloma presenting as vortex cry stalline keratopathy and complicated by endocapsular hematoma. Cornea 1992;11:584-5
15. de Alba Campomanes A, Rutar TM, Crawford JB, et al. Crystal-storing histiocytosis and crystalline keratopa thy caused by monoclonal gammopathy of undetermined significance. Cornea 2009;28:1081-4
16. Bowman Z, Peiffer RL Jr, Bouldin TW. Pathogenesis of ciliary-body cysts associated with multiple myeloma. Ann Ophthalmol 1988;20:292-5
17. Omoti AE, Omoti CE. Ophthalmic manifestations of multiple myeloma. West Afr J Med 2007;26:265-8.